DUBLIN--(BUSINESS WIRE)--The "Electrophysiology Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Electrophysiology Devices Market to Reach $14.8 Billion by 2027
Amid the COVID-19 crisis, the global market for Electrophysiology Devices estimated at US$7.9 Billion in the year 2020, is projected to reach a revised size of US$14.8 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027.
Electrophysiology Laboratory Devices, one of the segments analyzed in the report, is projected to record a 9.8% CAGR and reach US$5.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrophysiology Ablation Catheters segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 8.9% CAGR
The Electrophysiology Devices market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.
Electrophysiology Diagnostic Catheters Segment to Record 8.7% CAGR
In the global Electrophysiology Diagnostic Catheters segment, USA, Canada, Japan, China and Europe will drive the 8.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$715.7 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.7 Billion by the year 2027.
Select Competitors (Total 41 Featured):
- Abbott Laboratories, Inc.
- Biosense Webster, Inc.
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- CardioFocus, Inc.
- Medtronic PLC
- MicroPort Scientific Corporation
- Nihon Kohden Corporation
- Siemens Healthineers
- Stereotaxis, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- Impact of Covid-19 and a Looming Global Recession
- World Current & Future Analysis for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- World Historic Review for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- World 15-Year Perspective for Electrophysiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
- World 15-Year Perspective for Electrophysiology Laboratory Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Electrophysiology Ablation Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Electrophysiology Diagnostic Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Cardiac Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Atrial Fibrillation (AF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Atrial Flutter (AFL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 41
For more information about this report visit https://www.researchandmarkets.com/r/n04z38
